David Longstaff, Ph.D.

U.S. Food and Drug Administration Center for Veterinary Medicine (FDA CVM)

 

David Longstaff, Ph.D., received his B.Sc. (hons) in Microbiology and Genetics from the University of Aberdeen in Scotland, and M.S. and Ph.D. in Microbiology from The Ohio State University.

Longstaff joined the Office of New Animal Drug Evaluation in the Center for Veterinary Medicine at the U.S. Food and Drug Administration in 2008 as a reviewer in the Division of Manufacturing Technologies. After 8 years reviewing the chemistry, manufacturing and controls sections for all dosage forms and species, he transitioned to a team leader position in the Division of Generic Animal Drugs, where his focus is the use of in vitro data in support of bioequivalence.